Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression: An Open-Label Extension Trial

NCT05339074 is registered in ClinicalTrials.gov with Joshua Rosenblat as lead sponsor.

NCT NCT05339074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05339074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression: An Open-Label Extension Trial
Lead sponsor
Joshua Rosenblat
Phase
Phase 2
Overall status
Completed
Start date
August 11, 2022
Completion date
January 28, 2026
Enrollment
41 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, bipolar disorder, bipolar i disorder, bipolar ii disorder